Page 812 - Veterinary Immunology, 10th Edition
P. 812

disproportionately when more components are added to vaccines.
  VetBooks.ir  The success of a 21-component bluetongue vaccine in sheep or a 23-

               component Pneumococcal vaccine in AIDS patients should serve as
               a reassurance that multiple component vaccines are not

               overwhelming. Certainly such vaccines should be tested to ensure
               that all components induce a satisfactory response. Licensed
               vaccines provided by a reputable manufacturer will generally
               provide satisfactory protection against all components.



               Vaccination Schedules


               Although it is not possible to give exact schedules for all veterinary
               vaccines, certain principles are common to all methods of active
               immunization. Most vaccines require an initial series in which

               protective immunity is initiated, followed by revaccination (booster
               shots) at intervals to ensure that this protective immunity remains
               at an adequate level.



               Initial Series

               Because maternal antibodies passively protect newborn animals, it
               is not usually possible to successfully vaccinate very young
               animals. If stimulation of immunity is deemed necessary at this

               stage, the mother may be vaccinated during the later stages of
               pregnancy, the vaccinations being timed so that peak antibody
               levels are achieved at the time of colostrum formation. Once an
               animal is born, successful active immunization is effective only
               after passive immunity has waned. Since it is impossible to predict

               the exact time of loss of maternal immunity, the initial vaccination
               series will generally require administration of multiple doses.
               Current guidelines for essential canine and feline vaccines, for

               example, indicate that the first dose of vaccine should be
               administered at 8 to 9 weeks of age, followed by a second dose 3 to
               4 weeks later, and concluding at about 16 weeks of age. (These are
               not, strictly speaking, booster doses. They are simply designed to
               trigger a primary response as soon as possible after maternal

               immunity has waned.) All animals should then receive a booster
               dose 12 months later or at 1 year of age. Administration of vaccines
               to young animals is discussed in Chapter 23. It is unclear whether





                                                         812
   807   808   809   810   811   812   813   814   815   816   817